Review



c terminus sert  (Aviva Systems)


Bioz Verified Symbol Aviva Systems is a verified supplier
Bioz Manufacturer Symbol Aviva Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Aviva Systems c terminus sert
    C Terminus Sert, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4+Antibody+-+C+Terminus+(OAEB02575)/pmc11546934-257-3-8
    Average 92 stars, based on 1 article reviews
    c terminus sert - by Bioz Stars, 2026-09
    92/100 stars

    Images

    Related Articles

    In Utero:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Expressing:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Membrane:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Control:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Modification:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Western Blot:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    SDS Page:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Staining:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Labeling:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Marker:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Negative Control:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Positive Control:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Sequencing:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Phospho-proteomics:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Derivative Assay:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).

    Enzyme-linked Immunosorbent Assay:

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression
    Article Snippet: Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).Anti-SLC6A4 SERT 95 kDa antibody, LS-C156102 (internal), was from LSBio LifeSpan BioSciences, Inc. Anti-Serotonin Transporter (N-terminal) (SAB4200039) was from Sigma (St. Louis, MO, USA).. SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).. Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).Anti-ABCB1 P-gp mouse monoclonal antibody Clone 2F7 PGP) was obtained from OriGene (Rockville, MD, USA).



    Similar Products

    bs 1893r polyclonal rabbit serotonin transporter 5 htt ba09035094 antibody  (Bioss)
    93
    Bioss bs 1893r polyclonal rabbit serotonin transporter 5 htt ba09035094 antibody
    Bs 1893r Polyclonal Rabbit Serotonin Transporter 5 Htt Ba09035094 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4+5-HTT+Polyclonal+Antibody/pm39214056-71-36-45
    Average 93 stars, based on 1 article reviews
    bs 1893r polyclonal rabbit serotonin transporter 5 htt ba09035094 antibody - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    antibodies against sert  (Boster Bio)
    94
    Boster Bio antibodies against sert
    Antibodies Against Sert, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/Anti-Serotonin+transporter%2FSLC6A4+Antibody+Picoband/pm41814449-218-16-19
    Average 94 stars, based on 1 article reviews
    antibodies against sert - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    anti-slc6a4 polyclonal antibody k111482p  (Beijing Solarbio Science)
    90
    Beijing Solarbio Science anti-slc6a4 polyclonal antibody k111482p
    Heat map of molecular docking and parts of molecular docking visualization. (A) <t>SLC6A4-kaempferol,</t> (B) SLC6A4-quercetin.
    Anti Slc6a4 Polyclonal Antibody K111482p, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/anti+slc6a4+polyclonal+antibody+k111482p/pmc12014044-85-0-4
    Average 90 stars, based on 1 article reviews
    anti-slc6a4 polyclonal antibody k111482p - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    anti-slc6a4 sert 95 kda antibody, ls-c156102 (internal)  (Absolute Biotech Inc)
    90
    Absolute Biotech Inc anti-slc6a4 sert 95 kda antibody, ls-c156102 (internal)
    Heat map of molecular docking and parts of molecular docking visualization. (A) <t>SLC6A4-kaempferol,</t> (B) SLC6A4-quercetin.
    Anti Slc6a4 Sert 95 Kda Antibody, Ls C156102 (Internal), supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/anti+slc6a4+sert+95+kda+antibody++ls+c156102++internal+/pmc11546934-256-5-9
    Average 90 stars, based on 1 article reviews
    anti-slc6a4 sert 95 kda antibody, ls-c156102 (internal) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    c terminus sert  (Aviva Systems)
    92
    Aviva Systems c terminus sert
    Heat map of molecular docking and parts of molecular docking visualization. (A) <t>SLC6A4-kaempferol,</t> (B) SLC6A4-quercetin.
    C Terminus Sert, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4+Antibody+-+C+Terminus+(OAEB02575)/pmc11546934-257-3-8
    Average 92 stars, based on 1 article reviews
    c terminus sert - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    slc6a4 antibody  (Aviva Systems)
    92
    Aviva Systems slc6a4 antibody
    Effect of in utero opioid exposure on <t>SERT</t> and ABCB1 expression in human placental membranous vesicles. ( A ) Downregulation of SERT levels in qWestern blot analysis of protein lysates, comparing 20 first and second trimester opioid-exposed human placentas with 20 unexposed controls individually matched for fetal sex, GA, and maternal age. ( B ) Reduced levels of the drug transporter ABCB1 in opioid-exposed placentas. Inside out placental brush border membrane vesicles were used to measure and quantify the ABCB1 expression. In both ( A , B ), Grb2 served as a loading control. Data are presented as fold change (* for p < 0.05, *** for p < 0.001).
    Slc6a4 Antibody, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4+Antibody+-+C+Terminus+(OAEB02575)/pmc11546934-257-0-8
    Average 92 stars, based on 1 article reviews
    slc6a4 antibody - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    bs 1893r polyclonal rabbit serotonin transporter  (Bioss)
    93
    Bioss bs 1893r polyclonal rabbit serotonin transporter
    Effect of in utero opioid exposure on <t>SERT</t> and ABCB1 expression in human placental membranous vesicles. ( A ) Downregulation of SERT levels in qWestern blot analysis of protein lysates, comparing 20 first and second trimester opioid-exposed human placentas with 20 unexposed controls individually matched for fetal sex, GA, and maternal age. ( B ) Reduced levels of the drug transporter ABCB1 in opioid-exposed placentas. Inside out placental brush border membrane vesicles were used to measure and quantify the ABCB1 expression. In both ( A , B ), Grb2 served as a loading control. Data are presented as fold change (* for p < 0.05, *** for p < 0.001).
    Bs 1893r Polyclonal Rabbit Serotonin Transporter, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4+5-HTT+Polyclonal+Antibody/pmc11402036-329-42-53
    Average 93 stars, based on 1 article reviews
    bs 1893r polyclonal rabbit serotonin transporter - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    anti-slc6a4 antibody  (Abnova)
    90
    Abnova anti-slc6a4 antibody
    Effect of in utero opioid exposure on <t>SERT</t> and ABCB1 expression in human placental membranous vesicles. ( A ) Downregulation of SERT levels in qWestern blot analysis of protein lysates, comparing 20 first and second trimester opioid-exposed human placentas with 20 unexposed controls individually matched for fetal sex, GA, and maternal age. ( B ) Reduced levels of the drug transporter ABCB1 in opioid-exposed placentas. Inside out placental brush border membrane vesicles were used to measure and quantify the ABCB1 expression. In both ( A , B ), Grb2 served as a loading control. Data are presented as fold change (* for p < 0.05, *** for p < 0.001).
    Anti Slc6a4 Antibody, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/anti+slc6a4+antibody/us12016876-596-14-19
    Average 90 stars, based on 1 article reviews
    anti-slc6a4 antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    antibodies against slc6a4  (Novus Biologicals)
    94
    Novus Biologicals antibodies against slc6a4
    HQD affects <t>SLC6A4</t> expression and serotonin production in mouse colon tissues. (A) The ingredient-target-pathway/disease network of HQD in BATMAN-TCM. (B) The intersection of therapeutic targets screened in BATMAN-TCM and genes affected by Scutellaria baicalensis , Paeonia lactiflora , Glycyrrhiza uralensis , and Ziziphus jujuba in HERB 2.0. (C) Changes in SLC6A4 mRNA expression in AOM/DSS mice after HQD treatment detected by RT-qPCR. (D) Changes in SLC6A4 protein expression in AOM/DSS mice after HQD treatment detected by western blot assays. (E) Detection of serotonin (5-HT) production in mouse colon tissues by ELISA. The data are presented as the means ± SDs ( n = 6). *p < 0.05, ** p < 0.01, **** p < 0.0001. The data were analyzed by one-way ANOVA and Tukey’s multiple comparison test
    Antibodies Against Slc6a4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/slc6a4+antibody/SLC6A4%2F5-HTTLPR%2FSerotonin+transporter+Antibody/pmc10927794-58-23-28
    Average 94 stars, based on 1 article reviews
    antibodies against slc6a4 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Heat map of molecular docking and parts of molecular docking visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Heat map of molecular docking and parts of molecular docking visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Analysis results of the effect of causation between SLC6A4 and MDD.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Analysis results of the effect of causation between SLC6A4 and MDD.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Root-mean-square deviation visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Root-mean-square deviation visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Root-mean-square fluctuation visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Root-mean-square fluctuation visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Gyrate visualization. (A) SLC6A4-kaempferol, (B) SLC6A4-quercetin.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques:

    Immunohistochemistry for SLC6A4.

    Journal: Medicine

    Article Title: Investigating the mechanism of action of the Mongolian Medicine Areca Thirteen Pill (GY-13) in treating major depressive disorder based on integrated pharmacology

    doi: 10.1097/MD.0000000000042217

    Figure Lengend Snippet: Immunohistochemistry for SLC6A4.

    Article Snippet: Anti-SLC6A4 polyclonal antibody (K111482P, Solarbio) was used.

    Techniques: Immunohistochemistry

    Effect of in utero opioid exposure on SERT and ABCB1 expression in human placental membranous vesicles. ( A ) Downregulation of SERT levels in qWestern blot analysis of protein lysates, comparing 20 first and second trimester opioid-exposed human placentas with 20 unexposed controls individually matched for fetal sex, GA, and maternal age. ( B ) Reduced levels of the drug transporter ABCB1 in opioid-exposed placentas. Inside out placental brush border membrane vesicles were used to measure and quantify the ABCB1 expression. In both ( A , B ), Grb2 served as a loading control. Data are presented as fold change (* for p < 0.05, *** for p < 0.001).

    Journal: International Journal of Molecular Sciences

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression

    doi: 10.3390/ijms252111570

    Figure Lengend Snippet: Effect of in utero opioid exposure on SERT and ABCB1 expression in human placental membranous vesicles. ( A ) Downregulation of SERT levels in qWestern blot analysis of protein lysates, comparing 20 first and second trimester opioid-exposed human placentas with 20 unexposed controls individually matched for fetal sex, GA, and maternal age. ( B ) Reduced levels of the drug transporter ABCB1 in opioid-exposed placentas. Inside out placental brush border membrane vesicles were used to measure and quantify the ABCB1 expression. In both ( A , B ), Grb2 served as a loading control. Data are presented as fold change (* for p < 0.05, *** for p < 0.001).

    Article Snippet: SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).

    Techniques: In Utero, Expressing, Membrane, Control

    SERT is modified by maternal opioid exposure. ( A ) Immunoblot detection of SERT in placental vesicles of first and second trimester fetuses, using a rabbit polyclonal anti-serotonin transporter antibody specific for 70 kDa SERT. Grb2 served as a loading control. Subjects who admitted to chronic opioid use were compared to fetal sex-, GA-, and maternal age-matched controls. Left panel , lanes 1–4 are unexposed controls. Lanes 5–8 are subjects not exposed to opioids or EtOH but who were being treated for depression with SSRIs. Right panel , 12 opiod-exposed cases not exposed to other drugs. ( B ) Alteration of the SERT protein band pattern is seen only in opioid-exposed cases (lanes 4–10), not with other drug exposures—Adderall (lanes 1–3) and Keppra (lanes 11–12). The cleaved forms of SERT were observed only in opiate cases (lanes 4–10, top panel). ( C ) The smaller of the double-bands between 34 and 32 kDA representing cleaved forms of SERT (clSERT) in the opioid-exposed cases may represent a hypo-phosphorylated SERT fragment (see ).

    Journal: International Journal of Molecular Sciences

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression

    doi: 10.3390/ijms252111570

    Figure Lengend Snippet: SERT is modified by maternal opioid exposure. ( A ) Immunoblot detection of SERT in placental vesicles of first and second trimester fetuses, using a rabbit polyclonal anti-serotonin transporter antibody specific for 70 kDa SERT. Grb2 served as a loading control. Subjects who admitted to chronic opioid use were compared to fetal sex-, GA-, and maternal age-matched controls. Left panel , lanes 1–4 are unexposed controls. Lanes 5–8 are subjects not exposed to opioids or EtOH but who were being treated for depression with SSRIs. Right panel , 12 opiod-exposed cases not exposed to other drugs. ( B ) Alteration of the SERT protein band pattern is seen only in opioid-exposed cases (lanes 4–10), not with other drug exposures—Adderall (lanes 1–3) and Keppra (lanes 11–12). The cleaved forms of SERT were observed only in opiate cases (lanes 4–10, top panel). ( C ) The smaller of the double-bands between 34 and 32 kDA representing cleaved forms of SERT (clSERT) in the opioid-exposed cases may represent a hypo-phosphorylated SERT fragment (see ).

    Article Snippet: SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).

    Techniques: Modification, Western Blot, Control

    Cleaved SERT isoforms in opioid-exposed cases are within the central domain . ( A ) The immunoblot used for was used for detection of the central domain and C-terminal of SERT in placental vesicles from first and second trimester human pregnancies. Western immunoblots demonstrate expression of SERT isoforms in vesicles from 12-opioid exposed placentas at two GAs. Post-translational modification of SERT was studied by treatment with phosphatase inhibitors (Lane 5 vs. 6). This resulted in enhancement of the lower of the opioid-induced bands at 32–34 kDa, suggesting that most of this smaller clSERT is unphosphorylated. Antibodies to the N-terminal of SERT did not recognize either of the smaller (32 and 34 kDa) bands, while an antibody to the C-terminal region of SERT recognized both bands (upper panel), identical to the bands identified by antibodies to the central region of SERT (lower panel). SDS-PAGE stained with Coomassie blue was used to assure equal protein loading. The actin band (42 kDa) is labeled. ( B ) An antibody specific for the macrophage marker CD163 was used as a negative control, in combination with an antibody to GAPDH as a positive control, to confirm the purity of placental vesicles, the lack of contamination by other sources of SERT, and the specificity of the SERT double bands in panels ( A , B ) Note the absence of a band at 70 kDa.

    Journal: International Journal of Molecular Sciences

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression

    doi: 10.3390/ijms252111570

    Figure Lengend Snippet: Cleaved SERT isoforms in opioid-exposed cases are within the central domain . ( A ) The immunoblot used for was used for detection of the central domain and C-terminal of SERT in placental vesicles from first and second trimester human pregnancies. Western immunoblots demonstrate expression of SERT isoforms in vesicles from 12-opioid exposed placentas at two GAs. Post-translational modification of SERT was studied by treatment with phosphatase inhibitors (Lane 5 vs. 6). This resulted in enhancement of the lower of the opioid-induced bands at 32–34 kDa, suggesting that most of this smaller clSERT is unphosphorylated. Antibodies to the N-terminal of SERT did not recognize either of the smaller (32 and 34 kDa) bands, while an antibody to the C-terminal region of SERT recognized both bands (upper panel), identical to the bands identified by antibodies to the central region of SERT (lower panel). SDS-PAGE stained with Coomassie blue was used to assure equal protein loading. The actin band (42 kDa) is labeled. ( B ) An antibody specific for the macrophage marker CD163 was used as a negative control, in combination with an antibody to GAPDH as a positive control, to confirm the purity of placental vesicles, the lack of contamination by other sources of SERT, and the specificity of the SERT double bands in panels ( A , B ) Note the absence of a band at 70 kDa.

    Article Snippet: SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).

    Techniques: Western Blot, Expressing, Modification, SDS Page, Staining, Labeling, Marker, Negative Control, Positive Control

    SERT sequencing in opioid cases. The Edman degradation experiment was performed to get the N-terminal sequence of truncated SERT protein double-band versions in opioid-exposed placental vesicles. Two SERT fragments were present in the opioid samples. The sequences were compared with two 5HT transporter isoforms downloaded from Unipro. Sequence alignment was performed using ClustalW2 on two isoforms of SERT fragments on SLC6A4 (Synonyms:HTT, SERT; Organism Homo sapiens (Human), Taxonomic identifier9606 [NCBI]). The first four amino acids of the Central region of SERT were detected in two potential truncated bands corresponding to the sequence of SERT. In combination with the western blot results, we confirm the presence of a truncated SERT protein. Truncated proteins were located using the sequence alignment tool. Version 1 (the upper band) encompasses the amino acids 183–227 (out of 672) of human SERT. Truncated Version 2 (lower band) encompasses amino acids 224–276 of human SERT, which includes the phosphorylation site Thr276.

    Journal: International Journal of Molecular Sciences

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression

    doi: 10.3390/ijms252111570

    Figure Lengend Snippet: SERT sequencing in opioid cases. The Edman degradation experiment was performed to get the N-terminal sequence of truncated SERT protein double-band versions in opioid-exposed placental vesicles. Two SERT fragments were present in the opioid samples. The sequences were compared with two 5HT transporter isoforms downloaded from Unipro. Sequence alignment was performed using ClustalW2 on two isoforms of SERT fragments on SLC6A4 (Synonyms:HTT, SERT; Organism Homo sapiens (Human), Taxonomic identifier9606 [NCBI]). The first four amino acids of the Central region of SERT were detected in two potential truncated bands corresponding to the sequence of SERT. In combination with the western blot results, we confirm the presence of a truncated SERT protein. Truncated proteins were located using the sequence alignment tool. Version 1 (the upper band) encompasses the amino acids 183–227 (out of 672) of human SERT. Truncated Version 2 (lower band) encompasses amino acids 224–276 of human SERT, which includes the phosphorylation site Thr276.

    Article Snippet: SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).

    Techniques: Sequencing, Western Blot, Phospho-proteomics

    Prenatal alcohol exposure-associated downregulation of SERT and ABCB1 in placenta vesicles, placenta-derived exosomes, and fetal brain-derived exosomes. ( A ) EtOH exposure is associated with downregulation of total SERT in right side out (brush border membranous) placental vesicles (IOV) and placenta-derived exosomes from maternal blood (PE; bars 3–4) from human placenta tissues (n = 20) obtained from first and second trimester pregnancies. Analysis was completed by ELISA using a SERT ELISA kit, and results were obtained in picograms/microliters according to SERT standards. Bars represent fold changes between SERT levels in vesicles from EtOH-exposed cases compared to unexposed controls. ( B ) A similar reduction in expression of ABCB1 was seen in inside-out vesicles IOV. ( C ) Downregulation of SERT in fetal brain-derived exosomes. All assays were completed in triplicate (catalog #HS0096, detection range is within 0, 0.5, 1.0, 2.5, 5.0, 10 ng/mL, or picogram/microliter, and sensitivity is 0.1 ng/mL). ( *** for p < 0.001).

    Journal: International Journal of Molecular Sciences

    Article Title: Prenatal Opioid and Alcohol Exposures: Association with Altered Placental Serotonin Transporter Structure and/or Expression

    doi: 10.3390/ijms252111570

    Figure Lengend Snippet: Prenatal alcohol exposure-associated downregulation of SERT and ABCB1 in placenta vesicles, placenta-derived exosomes, and fetal brain-derived exosomes. ( A ) EtOH exposure is associated with downregulation of total SERT in right side out (brush border membranous) placental vesicles (IOV) and placenta-derived exosomes from maternal blood (PE; bars 3–4) from human placenta tissues (n = 20) obtained from first and second trimester pregnancies. Analysis was completed by ELISA using a SERT ELISA kit, and results were obtained in picograms/microliters according to SERT standards. Bars represent fold changes between SERT levels in vesicles from EtOH-exposed cases compared to unexposed controls. ( B ) A similar reduction in expression of ABCB1 was seen in inside-out vesicles IOV. ( C ) Downregulation of SERT in fetal brain-derived exosomes. All assays were completed in triplicate (catalog #HS0096, detection range is within 0, 0.5, 1.0, 2.5, 5.0, 10 ng/mL, or picogram/microliter, and sensitivity is 0.1 ng/mL). ( *** for p < 0.001).

    Article Snippet: SLC6A4 antibody to C-terminus SERT (OAEB02575) was from Aviva Systems Biology, Corp. (San Diego, CA, USA).

    Techniques: Derivative Assay, Enzyme-linked Immunosorbent Assay, Expressing

    HQD affects SLC6A4 expression and serotonin production in mouse colon tissues. (A) The ingredient-target-pathway/disease network of HQD in BATMAN-TCM. (B) The intersection of therapeutic targets screened in BATMAN-TCM and genes affected by Scutellaria baicalensis , Paeonia lactiflora , Glycyrrhiza uralensis , and Ziziphus jujuba in HERB 2.0. (C) Changes in SLC6A4 mRNA expression in AOM/DSS mice after HQD treatment detected by RT-qPCR. (D) Changes in SLC6A4 protein expression in AOM/DSS mice after HQD treatment detected by western blot assays. (E) Detection of serotonin (5-HT) production in mouse colon tissues by ELISA. The data are presented as the means ± SDs ( n = 6). *p < 0.05, ** p < 0.01, **** p < 0.0001. The data were analyzed by one-way ANOVA and Tukey’s multiple comparison test

    Journal: Functional & Integrative Genomics

    Article Title: Huang Qin decoction increases SLC6A4 expression and blocks the NFκB-mediated NLRP3/Caspase1/GSDMD pathway to disrupt colitis-associated carcinogenesis

    doi: 10.1007/s10142-024-01334-x

    Figure Lengend Snippet: HQD affects SLC6A4 expression and serotonin production in mouse colon tissues. (A) The ingredient-target-pathway/disease network of HQD in BATMAN-TCM. (B) The intersection of therapeutic targets screened in BATMAN-TCM and genes affected by Scutellaria baicalensis , Paeonia lactiflora , Glycyrrhiza uralensis , and Ziziphus jujuba in HERB 2.0. (C) Changes in SLC6A4 mRNA expression in AOM/DSS mice after HQD treatment detected by RT-qPCR. (D) Changes in SLC6A4 protein expression in AOM/DSS mice after HQD treatment detected by western blot assays. (E) Detection of serotonin (5-HT) production in mouse colon tissues by ELISA. The data are presented as the means ± SDs ( n = 6). *p < 0.05, ** p < 0.01, **** p < 0.0001. The data were analyzed by one-way ANOVA and Tukey’s multiple comparison test

    Article Snippet: After being blocked with skim milk for 45 min at room temperature, the PVDF membranes were incubated overnight at 4 °C with primary antibodies against SLC6A4 (1:1000, H00006532-D01P, Novus Biological Inc., Littleton, CO, USA), p-NFκB p65 (1:1000, #3033, Cell Signaling Technologies, Beverly, MA, USA), NFκB p65 (1:1000, #8242, Cell Signaling Technologies), NLRP3 (1:1000, #15,101, Cell Signaling Technologies), Cleaved-Caspase-1 P20 (1:1000, PA5-99390, Invitrogen), Cleaved-GSDMD (1:1000, #50,928, Cell Signaling Technologies), GSDMD (1:1000, ab225867, Abcam, Cambridge, UK), Caspase1 (1:1000, ab138483, Abcam), ASC (1:1000, #67,824, Cell Signaling Technologies), and β-actin (1:200, ab115777, Abcam).

    Techniques: Expressing, Biomarker Discovery, Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Comparison

    The therapeutic effect of HQD on AOM/DSS mice is inhibited after SLC6A4 knockout. AOM/DSS was used to establish WT and SLC6A4-deficient mice, which were subsequently treated with HQD. (A) Changes in the body weight of mice. (B) DAI of the mice. (C) Length of colon tissue in mice. (D) Number of tumors in the colon tissues of the mice. (E) HE staining of pathological morphology of the colon tissues. (F) Detection of 5-HT, IL-1β and IL-18 levels in mouse colon tissues by ELISA. (G) The expression of the p-NFκB p65, NLRP3, Cleaved-Caspase1 P20, Cleaved-GSDMD, and ASC proteins was determined in the colon tissue of AOM/DSS mice by western blot assay. The data are presented as the means ± SDs ( n = 6). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. The data were analyzed by an unpaired t-test or two-way ANOVA and Tukey’s multiple comparison test

    Journal: Functional & Integrative Genomics

    Article Title: Huang Qin decoction increases SLC6A4 expression and blocks the NFκB-mediated NLRP3/Caspase1/GSDMD pathway to disrupt colitis-associated carcinogenesis

    doi: 10.1007/s10142-024-01334-x

    Figure Lengend Snippet: The therapeutic effect of HQD on AOM/DSS mice is inhibited after SLC6A4 knockout. AOM/DSS was used to establish WT and SLC6A4-deficient mice, which were subsequently treated with HQD. (A) Changes in the body weight of mice. (B) DAI of the mice. (C) Length of colon tissue in mice. (D) Number of tumors in the colon tissues of the mice. (E) HE staining of pathological morphology of the colon tissues. (F) Detection of 5-HT, IL-1β and IL-18 levels in mouse colon tissues by ELISA. (G) The expression of the p-NFκB p65, NLRP3, Cleaved-Caspase1 P20, Cleaved-GSDMD, and ASC proteins was determined in the colon tissue of AOM/DSS mice by western blot assay. The data are presented as the means ± SDs ( n = 6). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. The data were analyzed by an unpaired t-test or two-way ANOVA and Tukey’s multiple comparison test

    Article Snippet: After being blocked with skim milk for 45 min at room temperature, the PVDF membranes were incubated overnight at 4 °C with primary antibodies against SLC6A4 (1:1000, H00006532-D01P, Novus Biological Inc., Littleton, CO, USA), p-NFκB p65 (1:1000, #3033, Cell Signaling Technologies, Beverly, MA, USA), NFκB p65 (1:1000, #8242, Cell Signaling Technologies), NLRP3 (1:1000, #15,101, Cell Signaling Technologies), Cleaved-Caspase-1 P20 (1:1000, PA5-99390, Invitrogen), Cleaved-GSDMD (1:1000, #50,928, Cell Signaling Technologies), GSDMD (1:1000, ab225867, Abcam, Cambridge, UK), Caspase1 (1:1000, ab138483, Abcam), ASC (1:1000, #67,824, Cell Signaling Technologies), and β-actin (1:200, ab115777, Abcam).

    Techniques: Knock-Out, Staining, Enzyme-linked Immunosorbent Assay, Expressing, Western Blot, Comparison

    SLC6A4 downregulation promotes MODE-K cell pyroptosis treated with DS. MODE-K cells were infected with sh-SLC6A4 or sh-NC, pre-treated with DS, and induced with LPS-ATP. (A) Detection of SLC6A4 mRNA expression in MODE-K cells after infection by RT-qPCR. (B) MODE-K cell viability was examined using a CCK-8 assay. (C) Measurement of LDH release. (D) The expression of NLRP3, Cleaved-Caspase1 P20, and Cleaved-GSDMD in MODE-K cells was examined using a western blot. (E) Immunofluorescence detection of ASC expression in MODE-K cells. The data are presented as the means ± SD ( n = 3). ** p < 0.01, **** p < 0.0001. The data were analyzed by unpaired t-test or two-way ANOVA and Tukey’s multiple comparison test

    Journal: Functional & Integrative Genomics

    Article Title: Huang Qin decoction increases SLC6A4 expression and blocks the NFκB-mediated NLRP3/Caspase1/GSDMD pathway to disrupt colitis-associated carcinogenesis

    doi: 10.1007/s10142-024-01334-x

    Figure Lengend Snippet: SLC6A4 downregulation promotes MODE-K cell pyroptosis treated with DS. MODE-K cells were infected with sh-SLC6A4 or sh-NC, pre-treated with DS, and induced with LPS-ATP. (A) Detection of SLC6A4 mRNA expression in MODE-K cells after infection by RT-qPCR. (B) MODE-K cell viability was examined using a CCK-8 assay. (C) Measurement of LDH release. (D) The expression of NLRP3, Cleaved-Caspase1 P20, and Cleaved-GSDMD in MODE-K cells was examined using a western blot. (E) Immunofluorescence detection of ASC expression in MODE-K cells. The data are presented as the means ± SD ( n = 3). ** p < 0.01, **** p < 0.0001. The data were analyzed by unpaired t-test or two-way ANOVA and Tukey’s multiple comparison test

    Article Snippet: After being blocked with skim milk for 45 min at room temperature, the PVDF membranes were incubated overnight at 4 °C with primary antibodies against SLC6A4 (1:1000, H00006532-D01P, Novus Biological Inc., Littleton, CO, USA), p-NFκB p65 (1:1000, #3033, Cell Signaling Technologies, Beverly, MA, USA), NFκB p65 (1:1000, #8242, Cell Signaling Technologies), NLRP3 (1:1000, #15,101, Cell Signaling Technologies), Cleaved-Caspase-1 P20 (1:1000, PA5-99390, Invitrogen), Cleaved-GSDMD (1:1000, #50,928, Cell Signaling Technologies), GSDMD (1:1000, ab225867, Abcam, Cambridge, UK), Caspase1 (1:1000, ab138483, Abcam), ASC (1:1000, #67,824, Cell Signaling Technologies), and β-actin (1:200, ab115777, Abcam).

    Techniques: Infection, Expressing, Quantitative RT-PCR, CCK-8 Assay, Western Blot, Immunofluorescence, Comparison

    A schematic drawing of HQD in CAC. Activation of SLC6A4 expression by HQD decreased the secretion of serotonin. After serotonin secretion was reduced, the NFκB pathway-induced NLRP3/Caspase1/GSDMD pyroptosis pathway was blocked, which alleviated CAC.

    Journal: Functional & Integrative Genomics

    Article Title: Huang Qin decoction increases SLC6A4 expression and blocks the NFκB-mediated NLRP3/Caspase1/GSDMD pathway to disrupt colitis-associated carcinogenesis

    doi: 10.1007/s10142-024-01334-x

    Figure Lengend Snippet: A schematic drawing of HQD in CAC. Activation of SLC6A4 expression by HQD decreased the secretion of serotonin. After serotonin secretion was reduced, the NFκB pathway-induced NLRP3/Caspase1/GSDMD pyroptosis pathway was blocked, which alleviated CAC.

    Article Snippet: After being blocked with skim milk for 45 min at room temperature, the PVDF membranes were incubated overnight at 4 °C with primary antibodies against SLC6A4 (1:1000, H00006532-D01P, Novus Biological Inc., Littleton, CO, USA), p-NFκB p65 (1:1000, #3033, Cell Signaling Technologies, Beverly, MA, USA), NFκB p65 (1:1000, #8242, Cell Signaling Technologies), NLRP3 (1:1000, #15,101, Cell Signaling Technologies), Cleaved-Caspase-1 P20 (1:1000, PA5-99390, Invitrogen), Cleaved-GSDMD (1:1000, #50,928, Cell Signaling Technologies), GSDMD (1:1000, ab225867, Abcam, Cambridge, UK), Caspase1 (1:1000, ab138483, Abcam), ASC (1:1000, #67,824, Cell Signaling Technologies), and β-actin (1:200, ab115777, Abcam).

    Techniques: Activation Assay, Expressing